Zfp951, identified as a zinc finger protein, assumes a pivotal role in the intricate orchestration of gene expression by virtue of its predicted DNA-binding transcription factor activities, particularly those specific to RNA polymerase II cis-regulatory region sequences. This zinc finger protein is anticipated to play a significant part in the regulation of transcription by RNA polymerase II, reflecting its involvement in the complex and tightly regulated processes governing the synthesis of RNA molecules from DNA templates. The orthologous relationship with the human ZNF101 emphasizes the evolutionary conservation of this transcriptional regulator, suggesting a fundamental and conserved role across species. The activation of Zfp951 involves a sophisticated interplay of molecular events that influence its DNA-binding and transcriptional regulatory functions. The predicted activation mechanisms are intricately linked to the modulation of chromatin structure and the epigenetic landscape. Histone deacetylase (HDAC) inhibitors, such as Trichostatin A, SAHA (Vorinostat), and Sodium Butyrate, are poised to activate Zfp951 by impacting histone acetylation, altering the accessibility of the chromatin, and facilitating the transcriptional machinery's access to the target genes.
Furthermore, DNA methyltransferase inhibitors, exemplified by 5-Azacytidine, have the potential to activate Zfp951 by influencing the epigenetic marks on CpG islands, thereby participating in the regulation of gene expression. In addition to these epigenetic influencers, Zfp951 may be activated through the modulation of RNA polymerase II activity. Glucocorticoid receptor agonists like Dexamethasone may influence transcription and activate Zfp951 by modulating the activity of RNA polymerase II. BET bromodomain inhibitors, represented by JQ1 and I-BET151, disrupt BET protein function, impacting RNA polymerase II cis-regulatory region binding and potentially activating Zfp951. These various chemicals, by targeting distinct cellular processes and signaling pathways, collectively contribute to the nuanced activation of Zfp951, shedding light on the intricate regulatory mechanisms that govern transcriptional dynamics within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor impacting histone acetylation, potentially activating Zfp951 by modulating chromatin structure and promoting transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor demethylating CpG islands, potentially activating Zfp951 by influencing the epigenetic regulation of transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist influencing transcription, potentially activating Zfp951 through the modulation of RNA polymerase II activity. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
RNA polymerase inhibitor disrupting transcription, potentially activating Zfp951 by influencing RNA polymerase II activity. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
Purine analog impacting nucleotide synthesis, potentially activating Zfp951 by influencing RNA polymerase II-specific DNA binding activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator affecting histone deacetylation, potentially activating Zfp951 by modulating chromatin structure and promoting transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor impacting histone acetylation, potentially activating Zfp951 by altering chromatin structure and promoting transcription. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor disrupting BET protein function, potentially activating Zfp951 by influencing RNA polymerase II cis-regulatory region binding. | ||||||